Cargando…

Immune Regulation during Chronic Visceral Leishmaniasis

Visceral leishmaniasis is a chronic parasitic disease associated with severe immune dysfunction. Treatment options are limited to relatively toxic drugs, and there is no vaccine for humans available. Hence, there is an urgent need to better understand immune responses following infection with Leishm...

Descripción completa

Detalles Bibliográficos
Autores principales: Faleiro, Rebecca J., Kumar, Rajiv, Hafner, Louise M., Engwerda, Christian R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091888/
https://www.ncbi.nlm.nih.gov/pubmed/25010815
http://dx.doi.org/10.1371/journal.pntd.0002914
_version_ 1782480813349142528
author Faleiro, Rebecca J.
Kumar, Rajiv
Hafner, Louise M.
Engwerda, Christian R.
author_facet Faleiro, Rebecca J.
Kumar, Rajiv
Hafner, Louise M.
Engwerda, Christian R.
author_sort Faleiro, Rebecca J.
collection PubMed
description Visceral leishmaniasis is a chronic parasitic disease associated with severe immune dysfunction. Treatment options are limited to relatively toxic drugs, and there is no vaccine for humans available. Hence, there is an urgent need to better understand immune responses following infection with Leishmania species by studying animal models of disease and clinical samples from patients. Here, we review recent discoveries in these areas and highlight shortcomings in our knowledge that need to be addressed if better treatment options are to be developed and effective vaccines designed.
format Online
Article
Text
id pubmed-4091888
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-40918882014-07-18 Immune Regulation during Chronic Visceral Leishmaniasis Faleiro, Rebecca J. Kumar, Rajiv Hafner, Louise M. Engwerda, Christian R. PLoS Negl Trop Dis Review Visceral leishmaniasis is a chronic parasitic disease associated with severe immune dysfunction. Treatment options are limited to relatively toxic drugs, and there is no vaccine for humans available. Hence, there is an urgent need to better understand immune responses following infection with Leishmania species by studying animal models of disease and clinical samples from patients. Here, we review recent discoveries in these areas and highlight shortcomings in our knowledge that need to be addressed if better treatment options are to be developed and effective vaccines designed. Public Library of Science 2014-07-10 /pmc/articles/PMC4091888/ /pubmed/25010815 http://dx.doi.org/10.1371/journal.pntd.0002914 Text en © 2014 Faleiro et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Review
Faleiro, Rebecca J.
Kumar, Rajiv
Hafner, Louise M.
Engwerda, Christian R.
Immune Regulation during Chronic Visceral Leishmaniasis
title Immune Regulation during Chronic Visceral Leishmaniasis
title_full Immune Regulation during Chronic Visceral Leishmaniasis
title_fullStr Immune Regulation during Chronic Visceral Leishmaniasis
title_full_unstemmed Immune Regulation during Chronic Visceral Leishmaniasis
title_short Immune Regulation during Chronic Visceral Leishmaniasis
title_sort immune regulation during chronic visceral leishmaniasis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091888/
https://www.ncbi.nlm.nih.gov/pubmed/25010815
http://dx.doi.org/10.1371/journal.pntd.0002914
work_keys_str_mv AT faleirorebeccaj immuneregulationduringchronicvisceralleishmaniasis
AT kumarrajiv immuneregulationduringchronicvisceralleishmaniasis
AT hafnerlouisem immuneregulationduringchronicvisceralleishmaniasis
AT engwerdachristianr immuneregulationduringchronicvisceralleishmaniasis